Follow @eaonc
 
  • Home
  • About Us
    • Organizational Overview
    • Executive Leadership
    • Governance
    • Membership
    • Scientific Planning and Review
    • Trial Monitoring
    • Operations
    • Biostatistics and Data Management
    • Collaborations
    • Active Clinical Trials
    • Participating Institutions
    • Scientific Achievements
    • Constitution
  • Scientific Programs
    • Cancer Control and Outcomes Program
    • Therapeutic Studies Program
    • Biomarker Sciences Program
  • Research Support
    • Research Support Committees
    • Mentorship
    • Training and Education
  • Research Cores
    • Central Biorepository and Pathology Facility
    • Imaging Core Laboratory
    • Leukemia Integrated Translational Science Center
    • Leukemia Tissue Bank
    • Thoracic Malignancies Integrated Translational Science Center
  • Resources
    • Group Meetings
    • Trial Educational Materials
    • NCI-MATCH / EAY131 for Researchers
    • Publications
    • ECOG Performance Status
    • ECOG-ACRIN Sample Tracking System
    • CIRB
    • Medidata Rave®
    • TRIAD™
    • SOAPP
    • PrECOG
    • Related Websites
    • Document Library
  • Patients
    • Myths and Facts
    • Resources
    • Trial Educational Materials
  • News and Info
    • Announcements
    • e-Newsletter
    • Press Releases
  • Contact Us
    • Donations
    • Locations
    • Office of Communications
    • Participating Institutions
    • Principal Investigators
Follow @eaonc
 

Trial Educational Materials

Educational Materials for Active Trials

Numerous clinical trials are always open and enrolling patients in the ECOG-ACRIN Cancer Research Group, which focuses its research on adults 18 years of age and older who have or are at risk of developing cancer. This section of the website contains all educational materials that are publicly available to patients and researchers.

To access educational materials for a particular trial, click on the trial ID in the list below. Materials for closed trials (no longer enrolling patients) can be found in the Archived Educational Materials section.

Cancer Type

Trial ID and Target Patient Population

Any Solid Tumor, Lymphoma, or Myeloma, or Cancer Type with No Standard Treatment Available NCI-MATCH / EAY131 – Eligibility Based on Genetic Testing
Brain EAF151 – Recurrent Glioblastoma
Breast EA1151 aka TMIST – Evaluating Two Current Mammography Methods for Breast Cancer Screening
EAI142 – Newly Diagnosed Metastatic Breast Cancer
EA1131 – Triple-Negative (Including Men)
EA1141 – Imaging Study for Women with Dense Breasts
E2112 – Advanced, Hormone Receptor-Positive and Resistant to Aromatase Inhibitors (Including Men)
ACRIN 6694 – Imaging Substudy for Women in the Alliance A011104 Trial
A011401 aka BWEL – Evaluating the Role of Weight Loss in Overweight Women with Early Breast Cancer
Gastrointestinal EA2161 – Rapalog-Resistant Advanced Pancreatic Neuroendocrine Tumors
EA2133 – Advanced Anal Cancer- Inoperable, Locally Recurrent or Metastatic
EA2142 – Advanced G3 Non-Small Cell Gastroenteropancreatic Neuroendocrine Carcinomas
EA2131 – Advanced Pancreatic
ACRIN 7151 – Detection of Colon Cancer (By Invitation Only)
Genitourinary EA8143 aka PROSPER RCC – Renal Cell Carcinoma
EA8134 aka InPACT – Penile Advanced Cancer
EA8141 – Upper Urinary Tract
E2810 – Advanced Renal Cell
Head and Neck E3311 – Locally Advanced HPV-Positive Throat
EA3132 – p53 Mutated, Surgically Resected Squamous Cell Carcinoma of the Head and Neck (SCCHN)
Leukemia EAI141 – Acute Myeloid
E1910 – Acute Lymphoblastic (ALL)
E2906 – Acute Myeloid (AML) in Adults 60 Years Old or Older
NHLBI-MDS aka The National MDS Study – Observation of Myelodysplastic Syndromes (MDS)
Lymphoma E4412 – Hodgkin
Melanoma EA6134 – Advanced, BRAFV600 Mutant
EA6141 – Advanced
E3612 – Advanced, Not Removable by Surgery
Myeloma E1A11 aka ENDURANCE – Symptomatic
E3A06 – Asymptomatic High-Risk Smoldering
Patient-Centered Outcomes E1Q11 aka EROS – Reproductive Health Planning
and Survivorship E1Z11 aka AIMSS – Genetic Predictors
EAQ152 aka COMET – Education in Tumor Profiling
Thoracic E4512, an ALCHEMIST treatment trial – Early, Non-Squamous Non-small Cell, Removed by Surgery
EA5142, an ALCHEMIST treatment trial – Non-small Cell, Post Surgery and Adjuvant Chemotherapy
ACRIN 4703 aka DECAMP-1 – Detection of Early Lung Cancer in Military Personnel
ACRIN 4704 aka DECAMP-2 – Screening of Military Personnel with Early Stage Lung Cancer or at High Risk of Developing Lung Cancer
ACRIN 6697 – Imaging Substudy for Patients in the RTOG 1106 Trial
Lung-MAP – Squamous Cell
2091
Resources
Group Meetings
Trial Educational Materials
  • Archived Educational Materials
NCI-MATCH / EAY131 for Researchers
Publications
ECOG Performance Status
CIRB
Medidata Rave®
TRIAD™
SOAPP
PrECOG
Related Websites
Document Library

© 2016 ECOG-ACRIN Cancer Research Group. All rights reserved.  |  Disclaimer